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Abstract 
Introduction: During the last decade, Malta experienced 
the introduction of a number of programmes and initiatives 
aiming to raise risk and cancer awareness on breast cancer. 
The aim of this retrospective study was to assess whether 
the rise in breast cancer awareness influenced the 
presentation pattern of breast cancer in Malta. 
Method: The patients’ records operated for breast 
cancer in the year 2000 and 2010 were reviewed after 
sourcing the list from the Pathology Department at Mater 
Dei Hospital. For each case demographics, laterality, 
surgical procedure, histology of tumour, largest 
histological tumour dimension, differentiation and nodal 
status were collected.  
Results: 456 patients were studied; 171 for the year 
2000 and 285 for the year 2010. Median age was 64 years 
(range 23-91 years) in 2000 and 59 years (range 29-96 
years) in 2010. Lumpectomy or wide local excision were 
carried out in 41.0% of patients in 2000 and 64.7% in 
2010. Mastectomy was done in 49.7% of patients in 
2000 and 27.1% in 2010.  Invasive ductal carcinoma 
of the unspecified type was the most common 
histological tumour in both years (68.8% in 2000, 
74.7% in 2010). Peak incidence for the histological 
tumour dimension shifted from pT2 in 2000 to pT1c in 
2010. Mean tumour size of the invasive type decreased 
from 28.2mm in the year 2000, to 22.9mm in the year 
2010 (p value = 0.007). Histological regional lymph 
node metastases decreased from 52.2% in 2000 to 
45.0% in 2010.   
Conclusion: Our study shows a trend of decrease in 
tumour size, less axillary node metastases and an 
increase in breast conservation surgery. Current 
initiatives and programmes appear to be effective at 
increasing breast cancer awareness.  
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Introduction 
          During the last decade, Malta experienced the 
introduction of a number of programmes and 
initiatives aiming to raise risk and symptom awareness 
on breast cancer and promoting early presentation. 
There also has been an increase in opportunistic 
screening, and the national breast screening 
programme (BSP) was started on the 7th October 2009. 
Increase in cancer awareness has been shown to lead 
to detection and treatment at early stages and better 
long-term survival.
1 
     The aim of this retrospective study was to assess 
whether this rise in breast cancer awareness influenced 
the presentation pattern of breast cancer in Malta. For 
this comparative study, patients that were operated for 
breast cancer in the year 2000 and 2010 were analysed.  
 
Method 
     The records of patients operated for breast cancer in 
the year 2000 and 2010 were reviewed after sourcing 
the list from the Pathology Department at Mater Dei 
Hospital. The histologies for both years included 
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patients operated at St. Luke’s Hospital/Mater Dei Hospital 
and private hospitals. 
     For each case the following data items were sought and 
documented if available: gender, age at the time of 
operation, laterality, surgical procedure, histological type 
of tumour, largest histological tumour dimension, 
histological differentiation and nodal status. This 
information was then compiled into an Excel worksheet. 
 
Results 
     This study was conducted on 456 patients, 171 for the 
year 2000 and 285 for the year 2010. In the year 2000, 
there were 168 (98.2%) females and 3 (1.8%) males. In the 
year 2010, there were 283 (99.3%) females and 2 (0.7%) 
males that were operated for breast cancer. Figure 1 
demonstrates the age distribution of these patients. 
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Figure 1: Age distribution of 
breast cancer patients
Year…
Year…
 
0%
20%
40%
60%
80%
100%
%
 o
f 
p
a
ti
en
ts
  
Age in years
Figure 2: The relation between 
the histological tumour size and 
age, for the year 2000 
pT
4
pT
3
pT
2
 
 
     The laterality of the breast tumour was noted. In the 
year 2000, 86 (50.3%) patients had breast cancer in the 
left breast, 83 (48.5%) patients in the right breast and 2 
(1.2%) patients had breast cancer in both breasts. In 
the year 2010, 131 (46.0%) patients had breast cancer 
on the left side, 147 (51.6%) patients on the right side, 
and 7 (2.1%) patients had breast cancer on both sides. 
     The following surgical procedures were performed: 
core biopsy or fine needle aspiration (FNA) only due 
to advanced age or other co-morbidities – 5 (2.9%) in 
2000 and 15 (5.1%) in 2010, lumpectomy or wide 
local excision (WLE) – 71 (41.0%) in 2000 and 189 
(64.7%) in 2010, mastectomy – 86 (49.7%) in 2000 
and 79 (27.1%) in 2010, other types of operations – 2 
(1.2%) in 2000 and 3 (1.0%) in 2010. There were 9 
(5.2%) advanced inoperable cases in 2000 and 6 
(2.1%) in 2010. 
     The histological details of the 464 breast tumours 
studied (8 patients out of the 456 patients studied had 
breast cancer on both sides and each were listed as 2 
separate tumours) were tabulated in table 1. The 
largest dimension of the primary tumour (pT) and the 
nodal status (pN) were classified according to the 
Breast Cancer Staging System of the American Joint 
Committee on Cancer (7
th
 edition). For the year 2010, 
there were 4 cases that received neoadjuvant 
chemotherapy and were classified according to the 
radiological measurements of the presenting tumour. 
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Histological type of tumour 
 
Year 2000 Year 2010 
Carcinoma, nos* 6 (3.5%) 3 (1.0%) 
In situ carcinoma (DCIS**, LCIS***, others) 16 (9.2%) 24 (8.2%) 
Invasive lobular carcinoma 14 (8.1%) 33 (11.3%) 
Invasive ductal carcinoma, nos* 119 (68.8%) 218 (74.7%) 
Invasive ductal carcinoma of specialised types (tubular, mucinous, others) 11 (6.4%) 9 (3.1%) 
Other carcinoma 7 (4.0%) 5 (1.7%) 
Primary Tumour (T)   
pTx (primary tumour cannot be assessed) 14 (8.1%) 23 (7.9%) 
pT0 (no evidence of primary tumour) 0 (0%) 1 (0.3%) 
pTis 16 (9.2%) 24 (8.2%) 
pT1mi (≤ 1mm in greatest dimension) 0 (0%) 4 (1.4%) 
pT1a (> 1mm but ≤ 5mm in greatest dimension) 5 (2.9%) 5 (1.7%) 
pT1b (> 5mm but ≤10mm in greatest dimension) 12 (6.9%) 22 ( 7.5%) 
pT1c (>10mm but ≤ 20mm in greatest dimension) 50 (29.0%) 108 (37.0%) 
pT2 (> 20mm but ≤ 50mm in greatest dimension) 58 (33.5%) 93 (31.8%) 
pT3 (> 50mm in greatest dimension) 14 (8.1%) 8 (2.7%) 
pT4 (tumour of any size with direct extension to chestwall and/or to the skin) 4 (2.3%) 3 (1.0%) 
Differentiation   
Unspecified differentiation 35 (20.2%) 16 (5.5%) 
Well differentiation (grade 1) 24 (13.9%) 82 (28.1%) 
Moderate differentiation (grade 2) 53 (30.6%) 133 (45.5%) 
Poor differentiation (grade 3) 61 (35.3%) 61 (20.9%) 
Nodal Status   
pNx (regional lymph nodes cannot be assessed) 60 (34.7%) 74 (25.3%) 
pN0 (no regional lymph nodes metastases histologically) 54 (31.2%) 120 (41.1%) 
pN1 (micrometastases; or metastases in 1-3 lymph nodes) 34 (19.7%) 61 (20.9%) 
pN2 (metastases in 4-9 lymph nodes) 15 (8.7%) 27 (9.2%) 
pN3 (metastases in 10 or more lymph nodes) 10 (5.8%) 10 (3.4%) 
Table 1: The histological characteristics of breast tumours 
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Discussion 
     Breast cancer is the most frequently diagnosed cancer and 
the leading cause of cancer death in Maltese females (Malta 
Cancer Registry). In contrast, male breast carcinoma is rare, 
accounting for less than 1% of all cases of breast carcinoma.
2
 
The large difference noted between the number of cases for 
the year 2000 and 2010 may be attributed to the incidence of 
female breast cancer in Malta which had increased from 2000 
to 2010. Also in 2000 the breast clinic at St. Luke’s hospital 
had just started and by 2010 more patients were referred to 
this clinic where data collection is better. 
     A shift from mastectomy towards breast conserving 
surgery was noted in our study. In the year 2000, mastectomy 
with axillary surgery was the commonest type of operation 
performed but in 2010, the commonest type of operation 
performed was lumpectomy/WLE with axillary surgery. 
During the period studied, it has been accepted that the 
outcome after breast cancer surgery and radiotherapy is 
equivalent to that in patients undergoing mastectomy.
3,4  
     From the histological type of tumour point of view, there 
was no significant difference between the 2 years. The 
invasive ductal carcinoma of the unspecified type was the 
most common type of histological tumour in both years. A 
small increase in the number of invasive lobular carcinoma 
was noted in 2010. This coincides with other studies which 
demonstrates that the incidence of invasive lobular carcinoma 
is rising, and this is mainly attributed to increased used of 
hormone replacement therapy and in vitro fertilization, 
improved diagnostic tools and more accurate pathological 
classification and diagnosis.
5,6
 A small decline in the 
incidence of in situ carcinoma was noted in 2010. 
     The peak incidence for the largest histological dimension 
of the tumour shifted from pT2 in the year 2000 to pT1c in 
the year 2010. A decline in the mean tumour size of more 
than 5mm was also detected. The mean tumour size of the 
invasive type decreased from 28.2mm in the year 2000, to 
22.9mm in the year 2010 (p value = 0.007). Part of this 
decline was found to be attributed to the effect of the national 
BSP. Out of the 291 tumours studied for the year 2010, 43 
were detected through the BSP, and 33 of these were of the 
invasive type. The mean tumour size of these 33 tumours was 
16.2 mm, while the mean tumour size of the other 209 
tumours of the year 2010 was 23.9mm. When comparing the 
mean tumour size of the year 2000 (28.2mm) with the mean 
tumour size of the 209 patients of the year 2010 (23.9mm), 
the decline in the mean tumour size was also statistically 
significant (p value = 0.037). 
     The median age of patients with breast cancer decreased 
from 64 years (23 years to 91 years) in 2000 to 59 years (29 
years to 96 years) in 2010, but this decline was not of 
statistical significance (p value = 0.23). 
     The relation between the histological tumour size and the 
age of the patients at the time of operation is demonstrated in 
Figures 2 and 3. In 2010, patients aged less than 80 years 
presented with a smaller breast tumour. Older patients did not 
follow this pattern as a rise in the number of large breast 
tumours (pT2, pT3, pT4) was noted in patients aged 80 
years and over. This is in keeping with several other 
studies which show that breast cancer awareness in older 
age groups is poor, and thus they are more likely to delay 
their presentation with breast cancer.
7,8,9
  
 
     In our study, the peak incidence in the histological 
differentiation of the tumour shifted from poor 
differentiation in 2000 to moderate differentiation in 
2010. However, there may be a bias because only 79.8% 
of tumours were graded in 2000, while in 2010, 94.5% 
were graded.  
     This study also surveyed axillary lymph node status. 
The incidence of patients with histological regional 
lymph nodes metastases decreased from 52.2% in the 
year 2000 to 45.0% in the year 2010.     
 
Conclusion  
     Overall, our study shows a change in the pattern of 
presentation of carcinoma of the breast with a shift 
towards diagnosis at an earlier stage and an increase in 
breast conservation surgery. Current initiatives and 
programmes aiming to increase breast cancer awareness 
and early detection appear to be effective.  
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